The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...

What will a second Donald Trump presidency mean for the regulation of medicines in the U.S.? History isn’t likely to repeat ...

It’s hard to know exactly what change in Washington will mean for the health care industry starting next year. But we have ...

Following the clearance of an investigational new drug application from the FDA, a phase 1 trial will examine the novel ...

In an interview with NPR on Wednesday, Kennedy said Trump had already assigned him three tasks: to reduce the “corruption and ...

The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...

The integration of AI into drug submission and approval processes signifies a shift towards more efficient pharmaceutical ...

REMS programmes are typically implemented after drug approval when the FDA determines that a medication needs to be closely ...

Drug shortages in the U.S. are increasing in number and duration, primarily affecting generic and multi-sourced drugs that ...

Patient advocates are hoping for change under new director Michelle Tarver, while industry groups hope she will build on ...

A physician is raising the alarm about what he calls 'concern' in the health care industry about RFK Jr.'s potential role in ...